MASSIRONI, SARA
 Distribuzione geografica
Continente #
AS - Asia 2.550
NA - Nord America 2.460
EU - Europa 1.560
SA - Sud America 332
AF - Africa 48
OC - Oceania 4
Totale 6.954
Nazione #
US - Stati Uniti d'America 2.393
SG - Singapore 771
VN - Vietnam 683
CN - Cina 464
IT - Italia 384
HK - Hong Kong 371
RU - Federazione Russa 357
BR - Brasile 268
DE - Germania 227
IE - Irlanda 180
SE - Svezia 169
KR - Corea 57
GB - Regno Unito 56
IN - India 43
FR - Francia 38
ID - Indonesia 38
CA - Canada 33
MX - Messico 28
FI - Finlandia 24
PL - Polonia 23
AR - Argentina 21
NL - Olanda 20
UA - Ucraina 20
AT - Austria 19
BD - Bangladesh 18
ZA - Sudafrica 16
JP - Giappone 15
PH - Filippine 13
ES - Italia 12
PE - Perù 12
TR - Turchia 12
EC - Ecuador 10
IQ - Iraq 10
KE - Kenya 9
BE - Belgio 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
EG - Egitto 7
CO - Colombia 6
MA - Marocco 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
MM - Myanmar 5
MY - Malesia 5
PY - Paraguay 5
TW - Taiwan 5
AU - Australia 4
JO - Giordania 4
LT - Lituania 4
PK - Pakistan 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
BG - Bulgaria 2
DK - Danimarca 2
GA - Gabon 2
KG - Kirghizistan 2
PA - Panama 2
AM - Armenia 1
BJ - Benin 1
CG - Congo 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
PT - Portogallo 1
SN - Senegal 1
SR - Suriname 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 6.954
Città #
Singapore 565
Ann Arbor 510
Hong Kong 371
Ashburn 282
Ho Chi Minh City 213
Dublin 173
Hanoi 157
Frankfurt am Main 150
Chandler 118
Hefei 116
Milan 111
Los Angeles 85
New York 78
Dallas 75
Beijing 74
Fairfield 67
Wilmington 65
Santa Clara 63
Chicago 53
Shanghai 53
Seoul 49
Moscow 42
Princeton 41
Houston 39
Buffalo 36
The Dalles 35
Woodbridge 32
Jakarta 30
São Paulo 28
Seattle 26
London 25
Haiphong 24
Munich 23
Cambridge 22
Rome 22
Da Nang 21
Lawrence 20
Florence 19
Ha Long 18
Altamura 17
San Diego 17
Warsaw 17
Nuremberg 16
Biên Hòa 15
Guangzhou 15
Rio de Janeiro 15
Bắc Ninh 14
Hangzhou 14
Hải Dương 14
Ninh Bình 14
Phoenix 13
Thái Nguyên 13
Tokyo 13
Denver 12
Helsinki 12
Montreal 12
Orem 12
Bari 11
Salt Lake City 11
Stockholm 11
Lima 10
Atlanta 9
Bình Dương 9
Bắc Giang 9
Chennai 9
Dhaka 9
Mexico City 9
Bologna 8
Brooklyn 8
Davao City 8
Mumbai 8
Tashkent 8
Vũng Tàu 8
Boardman 7
Council Bluffs 7
Desio 7
Garbagnate Milanese 7
Johannesburg 7
Lang Son 7
Nairobi 7
Phủ Lý 7
Quận Bình Thạnh 7
Seo-gu 7
Toronto 7
Turku 7
Vienna 7
Boston 6
Brasília 6
Falls Church 6
Guayaquil 6
Kent 6
Miami 6
Pune 6
Quận Một 6
Quận Sáu 6
Uyen Hung 6
Vinh 6
Điện Bàn 6
Belo Horizonte 5
Brno 5
Totale 4.504
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 687
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 285
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 267
Understanding short bowel syndrome: Current status and future perspectives 254
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 254
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 245
High rates of 30-day mortality in patients with cirrhosis and COVID-19 243
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 241
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 236
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 221
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 195
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 187
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 178
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 177
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 168
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 166
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 158
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 158
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 157
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 152
Eosinophilic esophagitis: does age matter? 149
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 140
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 139
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 138
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 137
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 135
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 132
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 130
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 127
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 120
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 116
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 114
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 114
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 105
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 102
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 96
Systematic review-Pancreatic involvement in inflammatory bowel disease 92
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 90
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 88
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 87
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 81
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 71
Totale 7.132
Categoria #
all - tutte 26.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 70 63 70 47 47 44 47
2021/2022411 38 43 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.891 90 164 157 77 148 99 137 57 152 334 207 269
2025/20262.860 979 397 318 556 549 61 0 0 0 0 0 0
Totale 7.132